Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Smoking Cessation and Continued Risk in Cancer Patients (PDQ®)
Patient Version
Health Professional Version
En español
Last Modified:
08/14/2008
Nicotine Patches
Brand
Dose
Side Effects
Comments
OTC = over the counter; Rx = prescription.
Rx
Habitrol
7–21 mg/day
Erythema
Use for 6–12 weeks.
OTC
Nicoderm CQ
7–21 mg/day
Pruritus
Use for 6–12 weeks.
OTC
Nicotrol
5–15 mg/day
Burning at site
Use for 14–20 weeks.
Rx
ProStep
11–22 mg/day
Local irritation
Use for 6–12 weeks.
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute